Kasvutx
1 known investors
Kasvu is a drug-discovery company developing small-molecule neuroplastogens — selective positive allosteric modulators of the TrkB receptor — using an AI-powered 3D model of the receptor and structure-based drug design. Its molecules aim to improve neuronal plasticity and cognitive function as treatments for neuropsychiatric conditions and neurodegenerative diseases such as Alzheimer's and Parkinson's.
Founders & leadership
RM
Rafael MolinerCo-Founder & Principal Scientist
JM
Jami MandelinCEO
Investors · 1
Frequently asked questions
- What does Kasvutx do?
- Kasvu is a drug-discovery company developing small-molecule neuroplastogens — selective positive allosteric modulators of the TrkB receptor — using an AI-powered 3D model of the receptor and structure-based drug design. Its molecules aim to improve neuronal plasticity and cognitive function as treatments for neuropsychiatric conditions and neurodegenerative diseases such as Alzheimer's and Parkinson's.
- Who founded Kasvutx?
- Kasvutx was founded by Rafael Moliner.
- Who are Kasvutx's investors?
- Kasvutx's investors include Nordic Science Investments.